New report on asbestos litigation trend

The American Academy of Actuaries' Mass Torts Subcommittee have released a report, Current Issues in Asbestos Litigation, examining recent trends in asbestos litigation. Included is a brief overview of asbestos litigation and highlights of recent changes in the litigation environment.

According to the report, at least half a million more asbestos claims are expected to be filed over the next several decades. However, resources to compensate victims of asbestos diseases are limited and the litigation has resulted in at least 78 corporate bankruptcies.

Despite the huge costs, the asbestos litigation system has been inefficient, with only 41% of total spending reaching claimants. Two concerns identified in the report are: 1) the sickest individuals might not be compensated adequately or promptly, and 2) the majority of claimants in recent years have not shown signs of impairment, which has led to stricter medical criteria for bringing a claim in some forums.

While Congress has been debating the issue during the past few years, several state and local jurisdictions have implemented their own reforms. "Stricter medical criteria, combined with heightened scrutiny of potentially fraudulent claims, might lead to fewer mass settlements of pending claim inventories and will likely affect whether and how mass screening activities are conducted in the future," said Jenni Biggs, Chairperson of the subcommittee.

Projections of future asbestos costs are uncertain because historical data is incomplete, the litigation environment is changing, and asbestos diseases will emerge over the next several decades. "Claims for malignant diseases are estimable based on the population exposed, timing of exposure and disease latency. However, estimating the number of claims for nonmalignant diseases is much more difficult because of the complexity of the asbestos litigation environment," Biggs said. "Nonetheless, informed and objective analysis can provide meaningful support to the public policy debate."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.